The FDA was asked recently by the House Energy and Commerce Committee to turn over the results of the so-called Seas study from Oxford University. The results of this study shocked the medical society as well as investors.
The researchers from Oxford University found that risk of cancer in a group of patients taking Vytorin was unexpectedly higher than in the control group. And yet when the FDA submitted the results, it stated that the link between Vytorin and higher cancer risks wasn’t there. Funny though, how the study was submitted to the FDA but never to the House Commerce Committee, which investigates the safety of prescription drugs.
So, can we fully trust the FDA? It seems the answer is obvious.
health, Vytorin, cancer
Technorati Tags: health, Vytorin, cancer
You may also find interesting
This entry was posted on Saturday, August 2nd, 2008 at 4:38 pm and is filed under Do you know, General health. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Seafood Selection and Your Health
Bioidentical stimulators for rejuvenation
New Study Gives Us A Cancer Prevention Tip
How To Prevent Seasonal Depression
How to Treat Erectile Dysfunction
Angelina Jolie got slim fast, but how?
How To Keep Your Man: An Anti-Aging Perspective
Learn How To Make the Right Choice in your Health Protection Strategy
Sex Can Make You Healthier
Early Menopause Can Cause Stroke
There is a Way To Stop Smoking Without Chiantix
Diesel Exhaust Can Promote Heart Disease
Your Relationship Is a Key To Your Health
Can Sex Prevent Heart Attack?
Exposure to Second Hand Smoke Found To Increase Cancer Risk
Testosterone can prolong life
Antidepressants Do Not Prevent Suicide
Diet planning to loose weight